日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies

MTAP缺失在癌基因驱动的非小细胞肺癌中很常见,并可能使肿瘤对PRMT5抑制剂和靶向治疗联合治疗敏感。

Aldea, M; Lenahan, S; Locquet, M-A; Liao, L; Gasparro, M; Gokhale, P C; Ghigna, M-R; Ionescu, D N; Odintsov, I; Ngo, K; Wang, X; Aziz, S; Pecci, F; Garbo, E; Ivanova, E; Nakazawa, S; Kulesza, J; Tsai, J A; Zullo, L; Lee, J; Zielinska, M; Simon, S; Han, D; Marinello, A; Li, G; Rossato de Almeida, G; Huang, J; Paoloni, F; Gariazzo, E; Santo, V; Remon, J; Marks, J A; LoPiccolo, J; Florez, N; Nishino, M; Ricciuti, B; Luo, J; Barbie, D A; Planchard, D; Rotow, J K; Barlesi, F; Graf, R P; Feng, W W; Besse, B; Paweletz, C; Sholl, L; Shaw, A T; Jänne, P A

Mutational Signature in Cancers Following Solid Organ or Allogeneic Stem Cell Transplantation

实体器官或异基因干细胞移植后癌症的突变特征

Odintsov, Igor; Siegmund, Stephanie E; Mahadevan, Navin R; Church, Alanna J; Sholl, Lynette M; Nowak, Jonathan A

Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy.

对致癌MET融合基因的泛癌分析揭示了对MET靶向治疗具有不同敏感性的不同致病基因组亚群

Febres-Aldana Christopher A, Vojnic Morana, Odintsov Igor, Zhang Tom, Cheng Ryan, Beach Catherine Z, Lu Daniel, Mattar Marissa S, Gazzo Andrea M, Gili Leo, Harshan Manju, Ameri Ali, Machnicki Stephen, Xiao Xiuying, Lockwood William W, Zhou Xiao-Yan, Yao Qianlan, Drilon Alexander, Rekhtman Natasha, Shah Nameeta, Li Anqi, Liu Zebing, Yang Soo-Ryum, Davare Monika A, Ladanyi Marc, Somwar Romel

HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting Strategies

HER4 和 EGFR 激活 NRG1 融合驱动癌症中的细胞信号传导:对 HER2-HER3 特异性靶向与泛 HER 靶向策略的启示

Udagawa, Hibiki; Nilsson, Monique B; Robichaux, Jacqulyne P; He, Junqin; Poteete, Alissa; Jiang, Hong; Heeke, Simon; Elamin, Yasir Y; Shibata, Yuji; Matsumoto, Shingo; Yoh, Kiyotaka; Okazaki, Shogo; Masuko, Takashi; Odintsov, Igor; Somwar, Romel; Ladanyi, Marc; Goto, Koichi; Heymach, John V

Prevalence and Therapeutic Targeting of High-Level ERBB2 Amplification in NSCLC.

非小细胞肺癌中高水平ERBB2扩增的流行情况及治疗靶点

Odintsov Igor, Makarem Maisam, Nishino Mizuki, Bachert Sara Emily, Zhang Tom, LoPiccolo Jaclyn, Paweletz Cloud P, Gokhale Prafulla C, Ivanova Elena, Saldanha Aisha, Rudin Charles M, Lockwood William W, Ladanyi Marc, Somwar Romel, Jänne Pasi A, Sholl Lynette M

HER2 Antibody-Drug Conjugates Are Active against Desmoplastic Small Round Cell Tumor

HER2抗体-药物偶联物对促纤维增生性小圆细胞肿瘤有效

Zhang, Tom; Febres-Aldana, Christopher A; Liu, Zebing; Dix, Jenna-Marie; Cheng, Ryan; Dematteo, Raymond G; Lui, Allan J W; Khodos, Inna; Gili, Leo; Mattar, Marissa S; Lisanti, Jeanine; Kwong, Charlene; Linkov, Irina; Tipping, Murray J; de Stanchina, Elisa; Odintsov, Igor; Ladanyi, Marc; Somwar, Romel

Combination of MDM2 and Targeted Kinase Inhibitors Results in Prolonged Tumor Control in Lung Adenocarcinomas With Oncogenic Tyrosine Kinase Drivers and MDM2 Amplification

MDM2 与靶向激酶抑制剂联合使用可延长具有致癌酪氨酸激酶驱动和 MDM2 扩增的肺腺癌的肿瘤控制时间

Arielle Elkrief, Igor Odintsov, Roger S Smith, Morana Vojnic, Takuo Hayashi, Inna Khodos, Vladimir Markov, Zebing Liu, Allan J W Lui, Jamie L Bloom, Michael D Offin, Charles M Rudin, Elisa de Stanchina, Gregory J Riely, Romel Somwar, Marc Ladanyi

Preclinical evaluation of targeted therapies for central nervous system metastases

中枢神经系统转移瘤靶向治疗的临床前评估

Pfeil, Alexander J; Hale, Joshua D; Zhang, Tiger S; Wakayama, Kentaro; Miyazaki, Isao; Odintsov, Igor; Somwar, Romel

A visual-language foundation model for computational pathology

计算病理学的视觉语言基础模型

Lu, Ming Y; Chen, Bowen; Williamson, Drew F K; Chen, Richard J; Liang, Ivy; Ding, Tong; Jaume, Guillaume; Odintsov, Igor; Le, Long Phi; Gerber, Georg; Parwani, Anil V; Zhang, Andrew; Mahmood, Faisal

Author Correction: Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations

作者更正:Vepafestinib 是一种药理学上先进的 RET 选择性抑制剂,具有高中枢神经系统穿透性和对 RET 溶剂前沿突变的抑制活性。

Miyazaki, Isao; Odintsov, Igor; Ishida, Keiji; Lui, Allan J W; Kato, Masanori; Suzuki, Tatsuya; Zhang, Tom; Wakayama, Kentaro; Kurth, Renate I; Cheng, Ryan; Fujita, Hidenori; Delasos, Lukas; Vojnic, Morana; Khodos, Inna; Yamada, Yukari; Ishizawa, Kota; Mattar, Marissa S; Funabashi, Kaoru; Chang, Qing; Ohkubo, Shuichi; Yano, Wakako; Terada, Ryuichiro; Giuliano, Claudio; Lu, Yue Christine; Bonifacio, Annalisa; Kunte, Siddharth; Davare, Monika A; Cheng, Emily H; de Stanchina, Elisa; Lovati, Emanuela; Iwasawa, Yoshikazu; Ladanyi, Marc; Somwar, Romel